Medical Blog About Treatment Abroad

Standard therapy for glioblastoma is the combination of surgical removal of the tumor, chemotherapy / radiation therapy. Average life expectancy after diagnosis with standard treatment of glioblastoma is 15-17 months, and the 5-year survival rate does not exceed 5-10%. Supplementing the standard protocol with the dendritic...

The fast-growing stem cell biology has turned modern medicine upside down, providing new ways of thinking about how to cure the previously considered incurable diseases. The special property of stem cells to promote tissue regeneration and convert to different types of tissues has provided the basis for new stem cell-based solutions...

Glioblastoma is a relatively rare and extremely aggressive brain tumor. An extensive epidemiological survey has recorded that the mean incidence of glioblastoma is about 3.19 cases per 100,000 people per year. Its aggressiveness is due to the rate at which glioblastoma cells multiply and spread to normal brain tissue, thus making the disease...

The second most common cancer diagnosis in men and the fifth cause of cancer deaths all over the world is prostate cancer. GLOBOCAN 2018 reports that the number of new cases was 1,276,106 cases worldwide, with the main increase in developed countries. The mortality and the incidence are closely associated with age, and the rates...

Lung cancer is a fatal disease that remains extremely difficult to treat despite the current progress of modern medicine. It is one of the most prevalent types of cancer worldwide and accounts for a significant share of cancer mortality. While smoking is the primary cause, many other risk factors can increase the risk of developing lung cancer...

Cancer remains far too common across Europe. In 2022 alone, there were approximately 4.47 million new cancer diagnoses - that's nearly one in four people up to age 75 developing cancer in their lifetime. This scale of disease highlights why blending integrative oncology with robust, conventional cancer care has become essential...

Pressurized intraperitoneal aerosol chemotherapy (PIPAC) is a new treatment option for peritoneal carcinomatosis. The technique was developed in 2011 by scientists from the University Hospital of Louisiana, USA. The authors suggested PIPAC as an alternative to HIPEC (hyperthermic intraperitoneal chemotherapy) in patients with peritoneal...

Immunotherapy is an innovative method of cancer treatment, and one of the most promising innovations is dendritic cell therapy. This radical approach utilizes the strength of the immune system of the patient to attack cancer and destroy cancer cells. The 2011 Nobel Prize in Medicine, awarded to Ralph M. Steinman as a discoverer...